newsfilter
← Latest News
ACCESS Newswire·

EyeGate Pharma Reports Third Quarter 2020 Financial Results and Provides Business Update

EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or "the Company"), a clinical-stage company focused on developing products for treating disorders of the eye, today announced financial results for the quarter ended September 30, 2020 and provided an update on recent corporate and operational activities.